Nasdaq Approves Listing of Canary’s Staked Injective ETF
Nasdaq has approved the listing of Canary's staked Injective ETF, which would stake at least 90% of its INJ holdings and charge a 1.10% annual sponsor fee. The approval adds a regulated US product for Injective exposure. INJ is not in the known asset list, so no tracked symbol is tagged.
Read the full story on The Defiant
Also covered by
- Injective’s INJ ETF approval opens regulated US access, but trading has not begun The Cryptonomist
- Bitcoin holds above $80,000 after Wednesday’s jump as injective rallies on staked ETF listing CoinDesk
- Canary’s Staked INJ ETF Begins Trading on Nasdaq The Defiant
- Canary’s Injective ETF debuts on Nasdaq with exposure to staking rewards The Block
- Canary Capital Brings Injective to Nasdaq With New INJ Staked ETF Bitcoin.com News